BBLG · Bone Biologics Corp
$1.08
-0.02 (-1.82%)
At close · Jul 23
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about our ability to continue as a going concern within a reasonable period of time, which is considered to be one year after the date that the financial statements are issued. In addition, our independent registered public accounting firm, in their report on the Company's audited financial statements for the year ended December 31, 2025, expressed substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$1.92M
Shares
1.80M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.07B
0%
FY2020
Net Income
-$3.11M
+24.4%
FY2025
Operating Margin
-0.08%
+0.2pp
FY2020
Diluted EPS
-$2.65
+90.8%
FY2025
Operating Cash Flow
-$2.69M
+34.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | $1.07B | $1.07B | $1.07B | $1.07B | $1.07B | — | — | — | — | — | — | — | — | — | — | — | |
| $1567 | — | — | $1868 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $778.21K | $1.06M | $2.13M | $6.91M | $1.58M | $82.04K | $340.67K | $1.1M | $104.49K | $1.42M | $10.17M | $3.67M | $623.52K | $188.24K | — | — | — | — | — | — | — | — | |
| $2.22M | $2.17M | $2.09M | $2.52M | $2.09M | $1.02M | $484.34K | $1.35M | $2.69M | $3.96M | $5.65M | $8.33M | $1.51M | $483.75K | — | — | — | — | — | — | — | — | |
| $3M | $3.23M | $4.22M | $9.43M | $3.67M | $1.1M | $825.01K | $2.45M | $2.79M | $2.63M | $20.41M | $12M | $3.01M | $671.99K | $58.6K | $53.37K | — | — | — | — | — | — | |
| -$3M | -$3.23M | -$4.22M | -$9.43M | -$3.67M | -$1.1M | -$825.01K | -$2.45M | -$2.79M | -$2.63M | -$20.41M | -$12M | -$3.01M | -$671.99K | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | -0.08% | -0.23% | -0.26% | -0.25% | -1.91% | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | $105.67K | $1.4M | $409.42K | $15 | $15 | — | — | — | — | — | — | |
| $143.62K | $125.95K | $106.74K | $479.57K | $2.18M | -$507.61K | -$998.08K | -$975.77K | -$1.64M | -$4.42M | -$5.46M | -$1.87M | -$1.41M | -$409.42K | — | — | — | — | — | — | — | — | |
| -$2.52M | — | — | — | — | -$1.61M | -$1.82M | -$3.42M | -$4.43M | -$7.05M | -$25.88M | -$13.87M | -$4.42M | -$1.08M | -$58.6K | -$53.37K | — | — | — | — | — | — | |
| — | — | — | — | — | $1600 | $1600 | $1603 | $1729 | $1600 | $2243 | $8840 | $1600 | $800 | — | — | — | — | — | — | — | — | |
| -$2.86M | -$3.11M | -$4.11M | -$8.95M | -$1.48M | -$1.61M | -$1.82M | -$3.42M | -$4.43M | -$7.05M | -$25.88M | -$13.88M | -$4.42M | -$1.08M | -$715.57K | -$937.63K | -$897.71K | -$1.2M | -$1M | -$1.22M | -$476.47K | -$50.76K | |
| — | — | — | — | — | — | -0.17% | -0.32% | -0.41% | -0.66% | -2.42% | — | — | — | — | — | — | — | — | — | — | — | |
| — | -$3.11M | -$7.32M | -$8.95M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| USD/shares | — | -$2.65 | -$28.96 | -$204.06 | -$186.90 | -$504.00 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$2.65 | -$28.96 | -$204.06 | -$186.90 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 1.17M | 252.96K | 43.86K | 7943 | 3154.0701 | 2021.759 | 5062.9486 | 3490.0576 | 2703.6667 | 26.13K | 19.77K | 10.38K | 7588.9576 | 3472.2222 | — | — | — | — | — | — | — |
| shares | — | 1.17M | 252.96K | 43.86K | 7943 | 3154.0701 | 2021.759 | 5062.9486 | 3490.0576 | 2703.6667 | 26.13K | 19.77K | 10.38K | 7588.9576 | 3472.2222 | — | — | — | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Biotechnology median 8.41×
EV/EBIT
—
Biotechnology median 26.60×
P/E (TTM)
—
Biotechnology median 7.07×